Literature DB >> 16606773

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Sandrine Greffard1, Marc Verny, Anne-Marie Bonnet, Jean-Yves Beinis, Claude Gallinari, Sylvie Meaume, François Piette, Jean-Jacques Hauw, Charles Duyckaerts.   

Abstract

BACKGROUND: How well the motor symptoms assessed by the motor section of the Unified Parkinson Disease Rating Scale (UPDRS3) reflect the neuronal loss observed in the substantia nigra is not known.
OBJECTIVE: To study the relationships among the motor symptoms assessed by the UPDRS3, Lewy body-associated neuronal loss in the substantia nigra, and duration of disease.
DESIGN: Longitudinal, prospective, clinicopathological study.
SETTING: Long-term care facility of a university hospital. PATIENTS: Eighteen elderly patients with a parkinsonian syndrome, studied prospectively but selected post mortem on the basis of the presence of Lewy bodies, and 5 age-matched control subjects.
METHODS: One map of a section of the substantia nigra, indicating the location of all the nucleolated neuronal profiles, was drawn for each case. Neuronal density was estimated using a tessellation method. The relationship between time and neuronal loss and between neuronal loss and motor symptoms (assessed by the UPDRS3) was studied by means of regression analysis, using linear and exponential models.
RESULTS: The neuronal density was linearly linked with the UPDRS3 score (r = -0.83 [P<.001]). Each point added to the UPDRS3 score corresponded to an estimated loss of 25 neurons/mm(3). The density of neuronal profiles in the substantia nigra decreased exponentially with time (r = -0.73 [P<.001]). Extrapolation of the curve suggested a presymptomatic phase of 5 years.
CONCLUSION: The UPDRS3 score is linearly linked to neuronal density, which, in Lewy body diseases, decreases exponentially with time at a similar pace in this series of elderly patients and in the younger patients described in the literature.

Entities:  

Mesh:

Year:  2006        PMID: 16606773     DOI: 10.1001/archneur.63.4.584

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  96 in total

1.  Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease.

Authors:  Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 2.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 3.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 4.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 5.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

6.  Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Authors:  Louise M Collins; Giorgia Dal Bo; Mariangela Calcagno; Jimena Monzón-Sandoval; Aideen M Sullivan; Humberto Gutierrez; Michele Morari; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

7.  Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.

Authors:  Sarah A McClymont; Paul W Hook; Alexandra I Soto; Xylena Reed; William D Law; Samuel J Kerans; Eric L Waite; Nicole J Briceno; Joey F Thole; Michael G Heckman; Nancy N Diehl; Zbigniew K Wszolek; Cedric D Moore; Heng Zhu; Jennifer A Akiyama; Diane E Dickel; Axel Visel; Len A Pennacchio; Owen A Ross; Michael A Beer; Andrew S McCallion
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

8.  Clinical profiles of late-onset psychiatric patients exhibiting incidental REM sleep without atonia.

Authors:  Hiroshige Fujishiro; Masato Okuda; Kunihiro Iwamoto; Seiko Miyata; Youta Torii; Shuji Iritani; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2019-06-22       Impact factor: 3.575

9.  Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.

Authors:  Aron S Buchman; Sukriti Nag; Joshua M Shulman; Andrew S P Lim; Veronique G J M VanderHorst; Sue E Leurgans; Julie A Schneider; David A Bennett
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 10.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.